Year: 2024
Type: article
Abstract: This Viewpoint discusses how data gaps in published research impede clinicians’ ability to clearly discuss the risks and benefits of amyloid-lowering drugs for treating Alzheimer disease.
Source: JAMA
Authors: Madhav Thambisetty, Robert Howard
Institutions: National Institute on Aging, University College London
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4396670105